Skip to content

Back to all articles

FDA greenlights Optellum's AI-powered software for early lung cancer diagnosis

24 March 2021

FDA greenlights Optellum's AI-powered software for early lung cancer diagnosis

In this post

Bio World Med Tech has published a detailed interview with Optellum CEO Vaclav Potesil. Read the full article here (you will need to subscribe or sign in to view.)

Jason Pesterfield, Optellum CEO, appears on Houston Innovators podcast

23 December 2022 / Events

Jason Pesterfield, Optellum CEO, appears on Houston Innovators podcast

Jason Pesterfield, Optellum CEO, appears on Houston Innovators podcast

150 most promising digital health companies of 2022, according to CB Insights

07 December 2022 / US

150 most promising digital health companies of 2022, according to CB Insights

150 most promising digital health companies of 2022, according to CB Insights

PRESS RELEASE: GE Healthcare and Optellum Join Forces to Advance Lung Cancer Diagnosis with Artificial Intelligence

26 November 2021 / Partnerships

PRESS RELEASE: GE Healthcare and Optellum Join Forces to Advance Lung Cancer Diagnosis with Artificial Intelligence

PRESS RELEASE: GE Healthcare and Optellum Join Forces to Advance Lung Cancer Diagnosis with Artificial Intelligence